Title : Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.

Pub. Date : 2015 Oct

PMID : 26374509






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Approximately 30% of patients treated with first-line immunomodulators (interferon-beta or glatiramer acetate) show a suboptimal response during the first 1-2 years and require a switch to an alternative therapy. Glatiramer Acetate interferon beta 1 Homo sapiens